Melanocortin agonism as a viable strategy to control alveolar bone loss induced by oral infection
| dc.creator | Mila Fernandes Moreira Madeira achou | |
| dc.creator | Tarcília Aparecida da Silva achou | |
| dc.creator | Mauro Perretti | |
| dc.creator | Celso Martins Queiroz-Junior | |
| dc.creator | Trinidad Montero-Melendez | |
| dc.creator | Sílvia Maria Cordeiro Werneck | |
| dc.creator | Jôice Dias Corrêa | |
| dc.creator | Frederico Marianetti Soriani | |
| dc.creator | Gustavo Pompermaier Garlet | |
| dc.creator | Souza Danielle Glória Souza | |
| dc.creator | Mauro Martins Teixeira | |
| dc.date.accessioned | 2025-04-16T16:41:40Z | |
| dc.date.accessioned | 2025-09-09T00:44:15Z | |
| dc.date.available | 2025-04-16T16:41:40Z | |
| dc.date.issued | 2016-12 | |
| dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| dc.description.sponsorship | FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais | |
| dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1096/fj.201600790r | |
| dc.identifier.issn | 1530-6860 | |
| dc.identifier.uri | https://hdl.handle.net/1843/81668 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | The FASEB Journal | |
| dc.rights | Acesso Restrito | |
| dc.subject | Aggregatibacter actinomycetemcomitans | |
| dc.subject | Inflammation | |
| dc.subject | Osteoclasts | |
| dc.subject | Periodontitis | |
| dc.subject | Melanocortins | |
| dc.subject | Evaluation study | |
| dc.subject | Periodontal diseases | |
| dc.subject | Alveolar bone loss | |
| dc.subject | Tumor necrosis factor-alpha | |
| dc.subject | Interferon-gamma | |
| dc.subject | Interleukin-17 | |
| dc.subject | Neutrophil Infiltration | |
| dc.subject | Periodontium | |
| dc.subject | Physiology | |
| dc.subject | Bone and bones | |
| dc.subject.other | Aggregatibacter actinomycetemcomitans | |
| dc.subject.other | DTrp8-γMSH | |
| dc.subject.other | Inflammation | |
| dc.subject.other | Osteoclasts | |
| dc.subject.other | Periodontitis | |
| dc.title | Melanocortin agonism as a viable strategy to control alveolar bone loss induced by oral infection | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 4041 | |
| local.citation.issue | 12 | |
| local.citation.spage | 4033 | |
| local.citation.volume | 30 | |
| local.description.resumo | Alveolar bone loss is a result of an aggressive form of periodontal disease (PD) associated with Aggregatibacter actinomycetemcomitans (Aa) infection. PD is often observed with other systemic inflammatory conditions, including arthritis. Melanocortin peptides activate specific receptors to exert antiarthritic properties, avoiding excessing inflammation and modulating macrophage function. Recent work has indicated that melanocortin can control osteoclast development and function, but whether such protection takes place in infection-induced alveolar bone loss has not been investigated. The purpose of this study was to evaluate the role of melanocortin in Aa-induced PD. Mice were orally infected with Aa and treated with the melanocortin analog DTrp8-γMSH or vehicle daily for 30 d. Then, periodontal tissue was collected and analyzed. Aa-infected mice treated with DTrp8-γMSH presented decreased alveolar bone loss and a lower degree of neutrophil infiltration in the periodontium than vehicle-treated animals; these actions were associated with reduced periodontal levels of TNF-α, IFN-γ, and IL-17A. In vitro experiments with cells differentiated into osteoclasts showed that osteoclast formation and resorptive activity were attenuated after treatment with DTrp8-γMSH. Thus, melanocortin agonism could represent an innovative way to tame over exuberant inflammation and, at the same time, preserve bone physiology, as seen after Aa infection. | |
| local.identifier.orcid | https://orcid.org/0000-0002-1770-9978 | |
| local.identifier.orcid | https://orcid.org/0000-0001-9623-7835 | |
| local.identifier.orcid | https://orcid.org/0000-0002-3563-376X | |
| local.identifier.orcid | https://orcid.org/0000-0002-5071-8382 | |
| local.identifier.orcid | https://orcid.org/0000-0003-0170-6163 | |
| local.identifier.orcid | https://orcid.org/0000-0003-4720-6746 | |
| local.identifier.orcid | https://orcid.org/0000-0002-6944-3008 | |
| local.identifier.orcid | https://orcid.org/0000-0003-2068-3331 | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAO - DEPARTAMENTO DE CLÍNICA | |
| local.publisher.department | ICB - DEPARTAMENTO DE BIOLOGIA GERAL | |
| local.publisher.department | ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA | |
| local.publisher.department | ICB - DEPARTAMENTO DE FARMACOLOGIA | |
| local.publisher.department | ICB - DEPARTAMENTO DE MICROBIOLOGIA | |
| local.publisher.department | ICB - DEPARTAMENTO DE MORFOLOGIA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.201600790R |
Arquivos
Licença do pacote
1 - 1 de 1